Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiludronic Acid in Advanced Otosclerosis
NCT01617057Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2012
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tiludronate in otosclerosis, sponsored by Assistance publique - Hôpitaux de Paris. Started May 2012; status: terminated.
02
Drugs
tiludronate
03
Conditions
otosclerosis
Beyond the preview
Go deeper on NCT01617057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01617057.